SEDIMENTATION RATE, ERYTHROCYTE
85651,85652
- 200.20 Burkitt's tumor or lymphoma, unspecified site, extranodal and solid organ sites
- 200.21 Burkitt's tumor or lymphoma involving lymph nodes of head, face, and neck
- 200.22 Burkitt's tumor or lymphoma involving intrathoracic lymph nodes
- 200.23 Burkitt's tumor or lymphoma involving intra-abdominal lymph nodes
- 200.24 Burkitt's tumor or lymphoma involving lymph nodes of axilla and upper limb
- 200.25 Burkitt's tumor or lymphoma involving lymph nodes of inguinal region and lower limb
- 200.26 Burkitt's tumor or lymphoma involving intrapelvic lymph nodes
- 200.27 Burkitt's tumor or lymphoma involving spleen
- 200.28 Burkitt's tumor or lymphoma involving lymph nodes of multiple sites
- 201.40 Hodgkin's disease, lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites
- 201.41 Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes of head, face, and neck
- 201.42 Hodgkin's disease, lymphocytic-histiocytic predominance involving intrathoracic lymph nodes
- 201.43 Hodgkin's disease, lymphocytic-histiocytic predominance involving intra abdominal lymph nodes
- 201.44 Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes of axilla and upper limb
- 201.45 Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes of inguinal region and lower limb
- 201.46 Hodgkin's disease, lymphocytic-histiocytic predominance involving intrapelvic lymph nodes
- 201.47 Hodgkin's disease, lymphocytic-histiocytic predominance involving spleen
- 201.48 Hodgkin's disease, lymphocytic-histiocytic predominance involving lymph nodes, multiple sites
- 201.50 Hodgkin's disease, nodular sclerosis, unspecified site, extranodal and solid organ sites
- 201.51 Hodgkin's disease, nodular sclerosis, involving lymph nodes of head, face, and neck
- 201.52 Hodgkin's disease, nodular sclerosis, involving intrathoracic lymph nodes
- 201.53 Hodgkin's disease, nodular sclerosis, involving intra-abdominal lymph nodes
- 201.54 Hodgkin's disease, nodular sclerosis, involving lymph nodes of axilla and upper limb
- 201.55 Hodgkin's disease, nodular sclerosis, involving lymph nodes of inguinal region and lower limb
- 201.56 Hodgkin's disease, nodular sclerosis, involving intrapelvic lymph nodes
- 201.57 Hodgkin's disease, nodular sclerosis, involving spleen
- 201.58 Hodgkin's disease, nodular sclerosis, involving lymph nodes of multiple sites
- 201.60 Hodgkin's disease, mixed cellularity, unspecified site, extranodal and solid organ sites
- 201.61 Hodgkin's disease, mixed cellularity, involving lymph nodes of head, face, and neck
- 201.62 Hodgkin's disease, mixed cellularity, involving intrathoracic lymph nodes
- 201.63 Hodgkin's disease, mixed cellularity, involving intra-abdominal lymph nodes
- 201.64 Hodgkin's disease, mixed cellularity, involving lymph nodes of axilla and upper limb
- 201.65 Hodgkin's disease, mixed cellularity, involving lymph nodes of inguinal region and lower limb
- 201.66 Hodgkin's disease, mixed cellularity, involving intrapelvic lymph nodes
- 201.67 Hodgkin's disease, mixed cellularity, involving spleen
- 201.68 Hodgkin's disease, mixed cellularity, involving lymph nodes of multiple sites
- 201.70 Hodgkin's disease, lymphocytic depletion, unspecified site, extranodal and solid organ sites
- 201.71 Hodgkin's disease, lymphocytic depletion, involving lymph nodes of head, face, and neck
- 201.72 Hodgkin's disease, lymphocytic depletion, involving intrathoracic lymph nodes
- 201.73 Hodgkin's disease, lymphocytic depletion, involving intra-abdominal lymph nodes
- 201.74 Hodgkin's disease, lymphocytic depletion, involving lymph nodes of axilla and upper limb
- 201.75 Hodgkin's disease, lymphocytic depletion, involving lymph nodes of inguinal region and lower limb
- 201.76 Hodgkin's disease, lymphocytic depletion, involving intrapelvic lymph nodes
- 201.77 Hodgkin's disease, lymphocytic depletion, involving spleen
- 201.78 Hodgkin's disease, lymphocytic depletion, involving lymph nodes of multiple sites
- 201.90 Hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites
- 201.91 Hodgkin's disease, unspecified type, involving lymph nodes of head, face, and neck
- 201.92 Hodgkin's disease, unspecified type, involving intrathoracic lymph nodes
- 201.93 Hodgkin's disease, unspecified type, involving intra-abdominal lymph nodes
- 201.94 Hodgkin's disease, unspecified type, involving lymph nodes of axilla and upper limb
- 201.95 Hodgkin's disease, unspecified type, involving lymph nodes of inguinal region and lower limb
- 201.96 Hodgkin's disease, unspecified type, involving intrapelvic lymph nodes
- 201.97 Hodgkin's disease, unspecified type, involving spleen
- 201.98 Hodgkin's disease, unspecified type, involving lymph nodes of multiple sites
- 202.00 Nodular lymphoma, unspecified site, extranodal and solid organ sites
- 202.01 Nodular lymphoma involving lymph nodes of head, face, and neck
- 202.02 Nodular lymphoma involving intrathoracic lymph nodes
- 202.03 Nodular lymphoma involving intra-abdominal lymph nodes
- 202.04 Nodular lymphoma involving lymph nodes of axilla and upper limb
- 202.05 Nodular lymphoma involving lymph nodes of inguinal region and lower limb
- 202.06 Nodular lymphoma involving intrapelvic lymph nodes
- 202.07 Nodular lymphoma involving spleen
- 202.08 Nodular lymphoma involving lymph nodes of multiple sites
- 202.80 Other malignant lymphomas, unspecified site, extranodal and solid organ sites
- 202.81 Other malignant lymphomas involving lymph nodes of head, face, and neck
- 202.82 Other malignant lymphomas involving intrathoracic lymph nodes
- 202.83 Other malignant lymphomas involving intra-abdominal lymph nodes
- 202.84 Other malignant lymphomas involving lymph nodes of axilla and upper limb
- 202.85 Other malignant lymphomas involving lymph nodes of inguinal region and lower limb
- 202.86 Other malignant lymphomas involving intrapelvic lymph nodes
- 202.87 Other malignant lymphomas involving spleen
- 202.88 Other malignant lymphomas involving lymph nodes of multiple sites
- 240.0-240.9 Simple and unspecified goiter
- 241.0-241.9 Nontoxic nodular goiter
- 242.00-242.91 Thyrotoxicosis with or without goiter
- 245.0-245.9 Thyroiditis
- 246.8 Other specified disorders of thyroid
- 279.4 Autoimmune disease, not elsewhere classified
- 362.34 Transient arterial occlusion
- 379.91 Pain in or around eye
- 391.0 Acute rheumatic pericarditis
- 391.1 Acute rheumatic endocarditis
- 391.2 Acute rheumatic myocarditis
- 391.8 Other acute rheumatic heart disease
- 410.00-410.02 Acute myocardial infarction of anterolateral wall
- 410.10-410.12 Acute myocardial infarction of other anterior wall
- 410.20-410.22 Acute myocardial infarction of inferolateral wall
- 410.30-410.32 Acute myocardial infarction of inferoposterior wall
- 410.40-410.42 Acute myocardial infarction of other inferior wall
- 410.50-410.52 Acute myocardial infarction of other later wall
- 410.60-410.62 True posterior wall infarction
- 410.70-410.72 Subendocardial infarction
- 446.0 Polyarteritis nodosa
- 446.5 Giant cell arteritis
- 447.6 Arteritis, unspecified
- 556.0-556.9 Ulcerative colitis
- 696.0 Psoriatic arthropathy
- 710.0 Systemic lupus erythematosus
- 710.1 Systemic sclerosis, use additional code to identify manifestation
- 710.2 Sicca syndrome
- 710.4 Polymyositis
- 710.9 Unspecified diffuse connective tissue disease
- 714.0 Rheumatoid arthritis
- 714.1 Felty's syndrome
- 714.2 Other rheumatoid arthritis with visceral or systemic involvement
- 714.30 Polyarticular juvenile rheumatoid arthritis, chronic or unspecified
- 714.81 Rheumatoid lung
- 714.9 Unspecified inflammatory polyarthropathy
- 716.59 Unspecified polyarthropathy or polyarthritis, multiple sites
- 719.49 Pain in joint, multiple sites
- 720.0 Ankylosing spondylitis
- 725 Polymyalgia rheumatica
- 729.1 Myalgia and myositis, unspecified
- 733.99 Other disorders of bone and cartilage (e.g., relapsing polychondritis)
- 783.21 Loss of weight
- 784.0 Headache
- E933.1 Drugs, medicinal and biological substances causing adverse effects in therapeutic use, antineoplastic and immunosuppressive drugs
- E933.8 Drugs, medicinal and biological substances causing adverse effects in therapeutic use, other systemic agents, not elsewhere classified
- E935.6 Drugs, medicinal and biological substances causing adverse effects in therapeutic use, antirheumatics (antiphlogistics)
- E947.2 Drugs, medicinal and biological substances causing adverse effects in therapeutic use, antidotes and chelating agents, not elsewhere classified
- V10.72 Personal history of Hodgkin's disease
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Aurora Diagnostics Clinical Services is not responsible for consequences that may result from using such information. Aurora Diagnostics Clinical Services is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
